ALZAMEND NEURO, INC. Demutualization by Insurance Entity, Securities Issued, Price Per Share or Unit
ALZAMEND NEURO, INC. (ALZN) had Demutualization by Insurance Entity, Securities Issued, Price Per Share or Unit of $5.00 per share as of 2021-06-17, per its 10-K filed 2023-07-27.
Discontinued › Notes › Financial Services › Demutualization and Closed Block
us-gaap:DemutualizationByInsuranceEntitySecuritiesIssuedPricePerShareOrUnit · last filed 2023-07-27
- 2021-06-17: Demutualization by Insurance Entity, Securities Issued, Price Per Share or Unit $5.00.
| Period end | Demutualization by Insurance Entity, Securities Issued, Price Per Share or Unit |
|---|---|
| 2021-06-17 | $5.00 10-K · filed 2023-07-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B |